We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

3 hedge funds and large institutions have $16.6K invested in ENDRA Life Sciences in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

258% more capital invested

Capital invested by funds: $4.65K → $16.6K (+$12K)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more funds holding

Funds holding: 2 → 3 (+1)

0.43% more ownership

Funds ownership: 0.21% → 0.64% (+0.43%)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$18.1K
2
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$135
3
Bank of America
Bank of America
North Carolina
+$8

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$4.63K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$16.5K +$18.1K +4,695 New
Northwestern Mutual Wealth Management
2
Northwestern Mutual Wealth Management
Wisconsin
$123 +$135 +35 New
Bank of America
3
Bank of America
North Carolina
$21 +$8 +2 +50%
TRCT
4
Tower Research Capital (TRC)
New York
– -$4.63K -1,130 Closed

NDRA Hedge Fund Activity: Q2 2025 in Review

3 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2025, worth a combined $16.6K — up 258% from $4.65K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NDRA positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $18.1K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $4.63K sold.

  • 3 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2025, up from 2 in Q1 2025.
  • Funds reported $16.6K of ENDRA Life Sciences stock for Q2 2025, up 258% quarter-over-quarter.
  • 2 funds opened new ENDRA Life Sciences positions in Q2 2025 and 1 closed out, a net change of +1 holder.
  • The largest ENDRA Life Sciences buyer in Q2 2025 was UBS Group, an estimated $18.1K added.
  • The largest ENDRA Life Sciences seller in Q2 2025 was Tower Research Capital (TRC), an estimated $4.63K sold.

Based on aggregated 13F filings for Q2 2025.